<unk>  is indicated for use in combination with other chemotherapy agents to treat cancer. This can be with or without total body irradiation (TBI), as a conditioning treatment prior to allogeneic or autologous hematopoietic progenitor cell transplantation (HPCT) in hematological diseases in adults and children. These diseases include Hodgkin's disease and leukaemia.<unk>  is also used with high-dose chemotherapy with HPCT support to treat certain solid tumors in adult and children.<unk>  is used in the palliation of many neoplastic diseases. The best results are found in the treatment of adenocarcinoma of the breast, adenocarcinoma of the ovary, papillary thyroid cancer and bladder cancer.<unk>  is used to control intracavitary effusions caused by serosal neoplastic deposits. Intravesical use<unk>  is used as intravesical chemotherapy in bladder cancer. It may be used prophylactically to prevent seeding of tumor cells at cystoscopic biopsy; as an adjunctive agent at the time of biopsy; or as a therapeutic agent to prevent recurrence after cystoscopic resection of bladder tumor (transurethral resection of bladder tumor, TURBT). Efficacy in tumor control may reach 55%. The main toxicity of this therapy is bone marrow suppression due to systemic absorption of the drug.
Thiotepa
Somatrem
Neuropil
Somatrogon
Dynorphin
N-Acetylserotonin
Beta-Endorphin
Gluten exorphin